Imatinib inhibits various types of activ
β
Hui Chen; Koji Isozaki; Kazuo Kinoshita; Akiko Ohashi; Yasuhisa Shinomura; Yuji
π
Article
π
2003
π
John Wiley and Sons
π
French
β 150 KB
## Abstract Mutations of protoβoncogene cβKIT in gastrointestinal stromal tumors (GISTs) are considered to cause a constitutive activation of KIT responsible for their oncogenesis. Imatinib has therapeutic potential for GISTs because of its inhibitory effect on KIT kinase activity. To investigate t